Ebola Response in Congo: WHO-backed researchers in eastern Congo have started a trial testing a monoclonal antibody (MBP134) and an antiviral (including remdesivir) against the Bundibugyo Ebola outbreak, as cases rise to 1,400+ with 438 deaths. Rapid Testing Push: A global diagnostics alliance says the race for a rapid Bundibugyo antigen test has narrowed to five manufacturers, aiming for field trials in weeks so health workers can get results on the spot. Public Health & Lab Safety: New reporting on NIH’s Rocky Mountain Labs highlights a Crimean-Congo hemorrhagic fever exposure incident tied to a glove tear, with officials saying protocols were followed and there was no public risk. Wildlife Monitoring in Congo: The Jane Goodall Institute says new research has confirmed African manatees in the Tchimpounga Nature Reserve, supported by training and long-term acoustic monitoring. Water & Climate Science: A new study maps how the Congo River’s massive freshwater flow spreads into the Atlantic, using modeling and observations to track rotating currents that carry water far offshore. Nature-Based Climate Action: Africa’s science and policy circles are pushing stronger environmental laws and better financing for nature-based solutions, linking research to jobs, resilience, and justice. Digital Finance in Congo Region: Optasia’s trading update points to faster growth, with revenue gains expected to include the Republic of Congo as microfinancing traction expands.